Compare INUV & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INUV | MDAI |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | 78 |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.2M | 39.6M |
| IPO Year | 1996 | N/A |
| Metric | INUV | MDAI |
|---|---|---|
| Price | $2.38 | $1.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $12.67 | $3.25 |
| AVG Volume (30 Days) | 370.1K | ★ 518.3K |
| Earning Date | 03-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $86,209,305.00 | N/A |
| Revenue This Year | $12.82 | N/A |
| Revenue Next Year | $4.23 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.88 | N/A |
| 52 Week Low | $0.28 | $1.04 |
| 52 Week High | $6.27 | $3.21 |
| Indicator | INUV | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 47.24 | 66.46 |
| Support Level | $1.67 | $1.48 |
| Resistance Level | $3.64 | $1.76 |
| Average True Range (ATR) | 0.22 | 0.12 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 6.12 | 96.64 |
Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.